Preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2-and MyD88-dependent signaling pathway

被引:483
作者
Takeuchi, O
Kaufmann, A
Grote, K
Kawai, T
Hoshino, K
Morr, M
Muhlradt, PF
Akira, S
机构
[1] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan
[2] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Osaka, Japan
[3] Univ Marburg, Inst Immunol, D-3550 Marburg, Germany
[4] Gesell Biotechnol Forsch mbH, Immunobiol Res Grp, D-3300 Braunschweig, Germany
关键词
D O I
10.4049/jimmunol.164.2.554
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mycoplasmas and their membranes are potent activators of macrophages, the active principle being Lipoproteins and lipopeptides. Two stereoisomers of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 (MALP-2) differing in the configuration of the lipid moiety were synthesized and compared in their macrophage-activating potential, the R-MALP being >100 times more active than the S-MALP in stimulating the release of cytokines, chemokines, and NO, To assess the role of the Toll-like receptor (TLR) family in mycoplasmal lipopeptide signaling, the MALP-2-mediated responses were analyzed using macrophages from wild-type, TLR2-, TLR4-, and MyD88-deficient mice, TLR2- and MyD88-deficient cells showed severely impaired cytokine productions in response to R- and S-MALP, The MALP-induced activation of intracellular signaling molecules was fully dependent on both TLR2 and MyD88. There was a strong preference for the R-MALP in the recognition by its functional receptor, TLR2.
引用
收藏
页码:554 / 557
页数:4
相关论文
共 30 条
[1]   Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function [J].
Adachi, O ;
Kawai, T ;
Takeda, K ;
Matsumoto, M ;
Tsutsui, H ;
Sakagami, M ;
Nakanishi, K ;
Akira, S .
IMMUNITY, 1998, 9 (01) :143-150
[2]   Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2 [J].
Aliprantis, AO ;
Yang, RB ;
Mark, MR ;
Suggett, S ;
Devaux, B ;
Radolf, JD ;
Klimpel, GR ;
Godowski, P ;
Zychlinsky, A .
SCIENCE, 1999, 285 (5428) :736-739
[3]   Mycoplasmas: Sophisticated, reemerging, and burdened by their notoriety [J].
Baseman, JB ;
Tully, JG .
EMERGING INFECTIOUS DISEASES, 1997, 3 (01) :21-32
[4]   Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors [J].
Brightbill, HD ;
Libraty, DH ;
Krutzik, SR ;
Yang, RB ;
Belisle, JT ;
Bleharski, JR ;
Maitland, M ;
Norgard, MV ;
Plevy, SE ;
Smale, ST ;
Brennan, PJ ;
Bloom, BR ;
Godowski, PJ ;
Modlin, RL .
SCIENCE, 1999, 285 (5428) :732-736
[5]   Mycoplasmal lipopeptide MALP-2 induces the chemoattractant proteins macrophage inflammatory protein 1α (MIP-1α), monocyte chemoattractant protein 1, and MIP-2 and promotes leukocyte infiltration in mice [J].
Deiters, U ;
Mühlradt, PF .
INFECTION AND IMMUNITY, 1999, 67 (07) :3390-3398
[7]   A Mycoplasma fermentans-derived synthetic lipopeptide induces AP-1 and NF-κB activity and cytokine secretion in macrophages via the activation of mitogen-activated protein kinase pathways [J].
Garcia, J ;
Lemercier, B ;
Roman-Roman, S ;
Rawadi, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (51) :34391-34398
[8]   Bacterial modulins: A novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis [J].
Henderson, B ;
Poole, S ;
Wilson, M .
MICROBIOLOGICAL REVIEWS, 1996, 60 (02) :316-+
[9]  
HERBERT DL, 1994, SPORTS MED STAND MAL, V6, P62
[10]  
Hirschfeld M, 1999, J IMMUNOL, V163, P2382